IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $686 | +18.7% | 60 | 0.0% | 0.00% | – |
Q3 2023 | $578 | -56.2% | 60 | -51.6% | 0.00% | – |
Q2 2023 | $1,319 | +109.0% | 124 | +106.7% | 0.00% | – |
Q1 2023 | $631 | -15.1% | 60 | 0.0% | 0.00% | – |
Q4 2022 | $743 | -25.7% | 60 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 60 | -33.3% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 90 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 90 | +50.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | – | 60 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 60 | -25.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 80 | -14.0% | 0.00% | -100.0% |
Q4 2019 | $1,000 | 0.0% | 93 | -31.1% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 135 | +3.8% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 130 | -11.6% | 0.00% | – |
Q1 2019 | $2,000 | – | 147 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
13D Management LLC | 533,562 | $5,613,073 | 2.85% |
Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
EMC Capital Management | 43,315 | $456 | 0.38% |
Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |